ArticleFrontiers in immunology2026

Antibiotic exposure and indication-specific corticosteroid use differentially modulate outcomes of immune checkpoint inhibitor therapy in hepatobiliary malignancies.

Jiabao Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.